Ultromics logo
Startup

Ultromics

See Ultromics's full profile

BOOK A DEMO
Headquarters

United Kingdom

Founded Year

2017

Total Funding

$58.8M

Employees

51 - 200

Status

Active


About Ultromics

Ultromics is a global health technology company which provides autonomous echocardiography analysis through innovative AI solutions empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease.

Headquarters

Oxford, United Kingdom


General Information on Ultromics

Brand name Ultromics
Company name Ultromics Ltd.
Website https://www.ultromics.com/
Founded year 2017
Employees 51 - 200
Founding team

Paul Leeson

Ross Upton

Contact [email protected]

Find startup solutions in your specific business context

The INNOSPOT Startup Discovery platform helps you to find the right startup solutions by leveraging the world's most powerful Startup Search Engine analyzing millions of data points.
BOOK A DEMO

Recent News and Activity about Ultromics

Med-Tech Innovation 11.11.2021
Caption Health and Ultromics partnership to improve ultrasound

Together, the companies will jointly offer the Caption AI software platform alongside Ultromics’ EchoGo deep ultrasound analytics – allowing more providers the ability to perform ultrasounds and automatically calculate key indicators of heart function, which drive earlier and more accurate disease diagnosis.Access to proper cardiac health care is a global problem, leading to countless preventable deaths. A limited number of specialists are ...

Ultromics news
Cardiac Rhythm News 11.11.2021
Caption Health and Ultromics partner to increase availability of heart disease detection and management tools

Access to effective cardiac health care is a global issue, leading to countless preventable deaths. A limited number of specialists are available to perform and analyse cardiac ultrasounds – a key diagnostic procedure for identifying the beginning or progression of heart failure, valve disease, and coronary artery disease. According to a recent study , 46% of patients in the United States (US) diagnosed with heart failure in acute care settings ...

Ultromics news
Diagnostic & Invasive Cardiology 09.11.2021
Caption Health and Ultromics Partner to Wide Availability of AI-enabled Cardiac Ultrasound Tools

November 9, 2021 — Caption Health and Ultromics, developers of artificial intelligence (AI) to improve cardiac ultrasound diagnostics, announced a strategic partnership to accelerate cardiovascular disease detection and treatment for more patients in more accessible care settings. Together, the companies will jointly offer the Caption AI software platform alongside Ultromics’ EchoGo deep ultrasound analytics.The vendors said this will allow a ...

Aunt Minnie 09.11.2021
Caption Health and Ultromics combine efforts in heart ultrasound

The companies will jointly offer the Caption AI software platform with Ultromics' EchoGo deep ultrasound analytics software. Images acquired using Caption AI can now be analyzed through Ultromics' EchoGo program, which was designed for automated analysis of left ventricular volumes, ejection fraction, and cardiac strain, as well as diagnostic support of heart failure and coronary artery disease. The integrated capabilities are expected to be ...

Ultromics news
Technews 09.11.2021
Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands

AddThis Sharing Buttons Share to Twitter Twitter Share to Facebook Facebook Share to LinkedIn LinkedIn Collaboration will empower clinicians with AI-enhanced diagnostics for heart failure and coronary artery disease beyond the walls of the hospital BRISBANE, Calif. OXFORD, England and GUILFORD, Conn. Nov. 9, 2021 /PRNewswire/ -- Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced a strategic ...

Ultromics news
HIT Consultant News 09.11.2021
Caption Health, Ultromics Partner for AI-Powered Heart Disease Detection

What You Should Know: – Caption Health and Oxford University spin-out Ultromics have teamed up to empower a broader set of healthcare providers and put heart disease detection and management tools in more hands. This is a second strategic partnership that Caption Health secured in the last three months to enable earlier disease detection and management with AI-based guidance and diagnostics. – Together, the companies will offer the Caption AI™ ...

Ultromics news
India Pharmaceuticals News 09.11.2021
Health tech firms Ultromics and Caption Health partner to tackle cardiac disease

UK-based health tech firm Ultromics and Caption Health…

PharmaVOICE 29.09.2021
Ultromics Announces Collaboration with Janssen to Develop an AI-Powered Diagnostic Device for Patients with Amyloidosis with Cardiac Involvement

of Johnson & Johnson, to identify patients with amyloidosis with cardiac involvement from routine echocardiograms. The agreement was facilitated by Johnson & Johnson Innovation.Ultromics will work with the data science and oncology scientists at Janssen Research & Development to develop an AI tool to promote screening of patients at risk for the potential build-up of amyloid, an abnormal protein, in the heart. Without treatment, the build-up of ...

Global Legal Chronicle 24.08.2021
Ultromics' $33 Million Series B Funding

Founded in 2017 by Dr Ross Upton and Professor Paul Leeson, as a spin out from the University of Oxford and built-in partnership with the U.K.'s National Health Service (NHS). Ultromics' EchoGo Core and EchoGo Pro platforms quickly deliver highly accurate assessments of heart function that support the diagnosis of coronary artery disease, heart failure and amyloidosis. Ultromics provides autonomous echocardiography analysis through innovative AI ...

Ultromics news
Cardiovascular News 19.08.2021
Ultromics completes US$33 million Series B funding round

In a press release, the company said it will use the new funding to help accelerate the use of AI-enabled echocardiograms to help improve patient care, and bring improved diagnostic quality and resource savings to hospitals.“Echocardiograms uploaded to the cloud and analysed by AI are set to revolutionise cardiac disease treatment pathways by helping more people understand their risk of heart disease earlier and with greater accuracy,” said Ross ...

Ultromics news